Page last updated: 2024-10-29

ketamine and Granulocytic Leukemia

ketamine has been researched along with Granulocytic Leukemia in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bujok, G1
Knapik, P1
MacioĊ‚, Z1
Eilers, H1
Philip, LA1
Bickler, PE1
McKay, WR1
Schumacher, MA1

Other Studies

2 other studies available for ketamine and Granulocytic Leukemia

ArticleYear
[Abnormal reaction for anaesthetics in a critically ill child with acute myeloid leukemia--case report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:5-6

    Topics: Acute Disease; Anesthetics, Dissociative; Anti-Anxiety Agents; Benzodiazepines; Bone Marrow Transpla

2004
The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine.
    Anesthesia and analgesia, 2001, Volume: 93, Issue:1

    Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Drug Therapy, Combination; Drug Tolerance; Fem

2001